Filter
204
Filtered Results: 204
Text search:
myocarditis
Featured
Recommendations
30
New Publications
59
Language
Document type
Guidelines
82
No document type
74
Studies & Reports
23
Manuals
12
Fact sheets
11
Training Material
1
Resource Platforms
1
Countries / Regions
India
14
Latin America and the Carribbean
10
Argentina
10
Brazil
8
Global
6
Venezuela
6
Paraguay
6
Indonesia
6
Colombia
5
Germany
5
Rwanda
4
South Africa
4
Bolivia
3
Ecuador
3
El Salvador
2
Philippines
2
Mozambique
2
USA
2
Africa
2
Tanzania
2
West and Central Africa
2
Western and Central Europe
2
Bangladesh
2
Nepal
1
Kenya
1
Ukraine
1
Lesotho
1
Ghana
1
Sierra Leone
1
Chile
1
Nigeria
1
Peru
1
Zimbabwe
1
Congo, Democratic Republic of
1
Western Pacific Region
1
East and Southern Africa
1
Uganda
1
Nicaragua
1
Russia
1
Ethiopia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Guidelines
64
COVID-19
34
Studies & Reports
12
Chagas
8
Clinical Guidelines
6
NTDs & Others
6
Pediatrics
5
Vaccine-preventable Diseases
5
Drugs & Medical Equipment
5
Women & Child Health
5
Communicable Diseases
4
Paediatrics
4
Dermatology
4
Capacity Building
4
Immunization
4
Communicable Diseases
4
Dengue
4
HIV & STI
4
Disease Prevention & Control
4
Policies & Guidelines HIV & TB
3
Surgery & Anaesthesia
3
Dental & Eye Care
2
Child Health
2
Vector Control
2
Cardiovascular Diseases
2
Yellow Fever
2
Zika
1
Under-5 nutrition
1
Diabetes
1
Bacteriology
1
Humanitarian Aid
1
MPOX - Monkeypox
1
Maternal & Child Health
1
NCD
1
Hemorrhagic Fever
1
Policies
1
Statistics
1
General Guidelines
1
Gynaecology & Obstetrics
1
Key Resources
1
Toolboxes
Country specific documents
26
Long COVID/ Post-COVID Syndrome
13
Clinical Guidelines
11
Immunization Guidelines
7
Biontech/Pfizer Comirnaty
7
Moderna
6
Studies & Reports
5
Dengue
4
Inactivated COVID-19 Vaccines
4
Chagas
4
Surveillance
3
Paediatrics
3
Johnson & Johnson
3
Handbooks & Manuals
3
Overview, Studies & Reports
3
Substance Use Disorders & Addiction
3
Alcohol
2
Yellow Fever
2
Vaccination
2
Context & Facts, Travel Advice
2
Scientific & Research Studies
2
Communication Material
2
COVID-19 Vaccination
2
COVID-19 Vaccination Information
2
Booster Doses
2
Model Formulary
2
Mental Disorders
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Information & Education Material (IEC)
2
Chikungunya
2
Assessment & Studies
1
Meningitis Prevention & Control
1
Laboratory Guidance
1
Clinical Aspects, Treatment & Prevention
1
Treatment & Prevention
1
Clinical Aspects
1
Country specific
1
Influenza Prevention & Control
1
Diagnosis & Treatment PTSD in Children
1
Substance Use Disorders, Others
1
Influenza
1
Context, Facts & Travel Advice
1
Opoids
1
Stroke
1
Public Health
1
Laboratory & Sampling
1
Clinical Guidelines
1
Clinical Aspects
1
Diagnostics & Laboratory Guidance
1
Country Specific
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Blood Supply
1
Long-term Care Facilities
1
Logistics & Supply
1
mRna Vaccines general
1
Others
1
Reports & Studies
1
Guidelines & Manuals
1
Zoonoses
1
MPOX - Monkeypox
1
NTDs
1
Dengue & Chikungunya
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
NTDs General
1
Vector control
1
Leptospirosis
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Bipolar Affective Disorders
1
Prophylactic Treatment
1
Education of students & professionals
1
Self-harm & Suicide
1
Germany
1
Dengue Prevention & Control
1
Latin America & the Carribean
1
Clinical Guidelines
1
Chikungunya Prevention & Control
1
Anxiety Disorders
1
Antiretroviral Treatment ART
1
Depression
1
Case Definitions
1
Volunteers
1
Reports & Studies
1
Vaccination
1
Accessed: 06.04.2020
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will support nurses on better action and also on communication towards
their patients and families.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
24 May 2021; Guidance for vaccinators on how to store, prepare, draw up and administer COVID-19 vaccines Updated May 2021 · Western Cape Edition
Practical Approach to Care Kit: Vaccine
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where the disease is endemic, congenital CD (cCD...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the
South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of
the cases evolve into chronic...
Chagas disease (CD) is caused by Trypanosoma cruzi. When acquired, the
disease develops in stages. For diagnosis, laboratory confirmation is required, and an extensive assessment of the patient’s health should be performed. Treatment consists of the administration of trypanocidal drugs, which may...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
Leptospirosis is an infectious disease caused by pathogenic organisms belonging to the genus Leptospira, that are transmitted directly or indirectly from animals to humans. Leptospirosis is a major direct zoonosis. Humanto-human transmission occurs only very rarely.
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
